Literature DB >> 15824978

Anaerobic sepsis due to multidrug-resistant Bacteroides fragilis: microbiological cure and clinical response with linezolid therapy.

D W Wareham1, M Wilks, D Ahmed, J S Brazier, M Millar.   

Abstract

We describe the first reported case of anaerobic sepsis due to Bacteroides fragilis with simultaneous resistance to metronidazole, beta-lactams, beta lactam/beta-lactamase inhibitors, carbapenems, macrolides, and tetracyclines. Microbiological cure and clinical improvement was achieved with linezolid therapy, an agent that may be useful for the treatment of multidrug-resistant anaerobic infections.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15824978     DOI： 10.1086/428623

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  23 in total

1.  Two cases of infections due to multidrug-resistant Bacteroides fragilis group strains.

Authors:  Anastasia Katsandri; Joseph Papaparaskevas; Angeliki Pantazatou; Georgios L Petrikkos; Georgios Thomopoulos; Dimitra P Houhoula; Athina Avlamis
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

Review 2.  Antianaerobic antimicrobials: spectrum and susceptibility testing.

Authors:  Itzhak Brook; Hannah M Wexler; Ellie J C Goldstein
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

3.  Deficiency of the ferrous iron transporter FeoAB is linked with metronidazole resistance in Bacteroides fragilis.

Authors:  Yaligara Veeranagouda; Fasahath Husain; Renata Boente; Jane Moore; C Jeffrey Smith; Edson R Rocha; Sheila Patrick; Hannah M Wexler
Journal:  J Antimicrob Chemother       Date:  2014-07-14       Impact factor: 5.790

4.  Structures of Bacteroides fragilis uridine 5'-diphosphate-N-acetylglucosamine (UDP-GlcNAc) acyltransferase (BfLpxA).

Authors:  Alice Ngo; Kai T Fong; Daniel L Cox; Xi Chen; Andrew J Fisher
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2015-04-24

5.  In Vitro Activity of Tedizolid Compared to Linezolid and Five Other Antimicrobial Agents against 332 Anaerobic Isolates, Including Bacteroides fragilis Group, Prevotella, Porphyromonas, and Veillonella Species.

Authors:  Ellie J C Goldstein; C Vreni Merriam; Diane M Citron
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

6.  A focus on intra-abdominal infections.

Authors:  Massimo Sartelli
Journal:  World J Emerg Surg       Date:  2010-03-19       Impact factor: 5.469

7.  Two multidrug-resistant clinical isolates of Bacteroides fragilis carry a novel metronidazole resistance nim gene (nimJ).

Authors:  Fasahath Husain; Yaligara Veeranagouda; Justin Hsi; Rosemary Meggersee; Valerie Abratt; Hannah M Wexler
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

8.  Changes in the antibiotic susceptibility of anaerobic bacteria from 2007-2009 to 2010-2012 based on the CLSI methodology.

Authors:  Christine J Hastey; Halsey Boyd; Audrey N Schuetz; Karen Anderson; Diane M Citron; Jody Dzink-Fox; Meredith Hackel; David W Hecht; Nilda V Jacobus; Stephen G Jenkins; Maria Karlsson; Cynthia C Knapp; Laura M Koeth; Hannah Wexler; Darcie E Roe-Carpenter
Journal:  Anaerobe       Date:  2016-07-15       Impact factor: 3.331

Review 9.  Bacteroides: the good, the bad, and the nitty-gritty.

Authors:  Hannah M Wexler
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

10.  Alistipes finegoldii in blood cultures from colon cancer patients.

Authors:  Lukas Fenner; Véronique Roux; Pascal Ananian; Didier Raoult
Journal:  Emerg Infect Dis       Date:  2007-08       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.